Us Infection Prevention & Control Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Infection Prevention & Control Market was valued at USD 25.5 Billion in 2022 and is projected to reach USD 50.9 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
The United States infection prevention and control market is experiencing significant growth, driven by increasing healthcare-associated infections (HAIs) and stringent regulatory standards. In 2024, the market was valued at approximately USD 12.75 billion and is projected to reach USD 22.25 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.29% during the forecast period.
Several factors contribute to this expansion:
Rising Incidence of HAIs: The prevalence of HAIs has heightened the demand for effective infection control measures across healthcare settings.
Regulatory Compliance: Agencies such as the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) enforce strict guidelines, compelling healthcare facilities to adopt advanced infection prevention protocols.
Technological Advancements: Innovations in sterilization and disinfection technologies enhance the efficacy of infection control practices, further propelling market growth.
Personal protective equipment (PPE) plays a pivotal role in infection prevention. The market has seen a surge in demand for disposable hospital gowns, with projections indicating a robust CAGR of over 13% from 2024 to 2030. This trend underscores the emphasis on safeguarding both healthcare workers and patients from potential infections.
Moreover, the introduction of advanced pharmaceutical interventions contributes to market dynamics. For instance, Gilead Sciences' development of lenacapavir, a twice-yearly injection, has demonstrated a 99.9% efficacy in preventing HIV infections. Such innovations not only address specific infections but also influence overall infection control strategies within healthcare systems.
However, challenges persist. The high costs associated with advanced infection control products and limited reimbursements, especially in developing regions, may hinder widespread adoption. Additionally, ensuring compliance among healthcare staff requires continuous training and monitoring.
In summary, the U.S. infection prevention and control market is poised for substantial growth, driven by increasing HAIs, regulatory mandates, and technological advancements. Stakeholders must navigate financial and operational challenges to effectively implement comprehensive infection control measures, ensuring patient and healthcare worker safety.
Get an In-Depth Research Analysis of the Global Infection Prevention & Control Market Size And Forecast [2025-2032]
Cook Medical
Medtronic Plc
Boston Scientific Corporation
CONMED Corporation
CORPAK MedSystems
CR Bard
ALCOR Scientific
Pacific Hospital Supply
Teleflexorporated
Vygon SA
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Infection Prevention & Control Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Infection Prevention & Control Market
Personal Protective Equipment (PPE)
Disinfectants and Antiseptics
Sterilization Equipment
Infection Control Software
Hospitals and Clinics
Long-term Care Facilities
Ambulatory Surgical Centers
Diagnostic Laboratories
Home Healthcare Settings
Airborne Infection Control
Contact Infection Control
Vector-borne Infection Control
Waterborne Infection Control
Healthcare-associated Infections (HAIs)
Bloodstream Infections
Respiratory Infections
Urinary Tract Infections
Surgical Site Infections
Operating Rooms
Patient Wards
Isolation Rooms
Laboratories
Emergency Departments
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Infection Prevention & Control Market Research Analysis
1. Introduction of the Global Infection Prevention & Control Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Infection Prevention & Control Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Infection Prevention & Control Market, By Type
6. Global Infection Prevention & Control Market, By Application
7. Global Infection Prevention & Control Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Infection Prevention & Control Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/